Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06535854 · ClinicalTrials.gov registry record · NA
Prevail Global Study
A NA study of Coronary Artery Disease, sponsored by Medtronic Vascular.
- Recruiting
- Registry status
- NA
- Development phase
- 1,205
- Enrollment target
- 20
- Study locations
NCT06535854 is a NA study of Coronary Artery Disease that is actively recruiting participants, run by Medtronic Vascular. The registered enrollment target is 1,205 participants, roughly in line with the 1,281-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target. The trial reports 20 study locations across 13 states.
The verdict
NCT06535854, a NA study of Coronary Artery Disease, is actively recruiting participants, sponsored by Medtronic Vascular.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,205 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.
Conditions Studied
Interventions
- DEVICE Prevail DCB
- DEVICE Agent DCB
Study Locations (20)
Florida
- BayCare Health System - Clearwater
- North Florida Regional Medical Center - Gainesville
- University of Miami Hospital - Miami
Alabama
- The University of Alabama at Birmingham - Birmingham
- Huntsville Hospital - Huntsville
Georgia
- Emory University Hospital Midtown - Atlanta
- Piedmont Atlanta Hospital - Atlanta
Illinois
- Advocate Illinois Masonic Medical Center - Chicago
- Midwest Cardiovascular Institute - Naperville
Kansas
- Kansas City Heart Rhythm Institute (Midwest Heart and Vascular Specialist) - Overland Park
- Ascension Via Christi Saint Francis - Wichita
Michigan
- Corewell Health - Grand Rapids
- Saint Joseph Mercy Ann Arbor - Ypsilanti
Arizona
- Carondelet Saint Marys - Tucson
Arkansas
- John L McClellan Memorial Veterans Hospital - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,205 participants |
| Start Date | 2025-02-24 |
| Est. Completion | 2031-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06535854
The ClinicalTrials.gov registry entry for NCT06535854 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,205 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,281-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target. The listed sponsor is Medtronic Vascular, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Prevail DCB is the first listed.
NCT06535854 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, Alabama, Georgia.
Frequently Asked Questions
What is clinical trial NCT06535854 about?
NCT06535854 is a clinical study titled "Prevail Global Study". The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.
What is the current status of trial NCT06535854?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,205 participants. The study started on 2025-02-24. Estimated completion is 2031-02.
What conditions does trial NCT06535854 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
What interventions are being tested in trial NCT06535854?
The interventions under investigation include: Prevail DCB (DEVICE), Agent DCB (DEVICE).
Who is sponsoring clinical trial NCT06535854?
This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06535854 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
-
Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.